News
Public · Published
Revolution Medicines to Participate in November 2026 Investor Conferences
Revolution Medicines said CEO Mark A. Goldsmith will take part in two investor conferences: a Guggenheim fireside chat on November 10 at 8:30 a.m. ET and a Jefferies fireside chat in London on November 16 at 5:30 a.m. ET.
Published:
Updated:
What happened
Revolution Medicines said CEO Mark A. Goldsmith will take part in two investor conferences: a Guggenheim fireside chat on November 10 at 8:30 a.m. ET and a Jefferies fireside chat in London on November 16 at 5:30 a.m. ET.
Confirmed
Global impact / market context
Investor conferences give company leaders a public setting to explain strategy and answer questions, which can shape how investors view the company. Webcast replays staying online for at least 14 days widen access for people who cannot listen live.
Analyst inference
Revolution Medicines is a commercial-stage oncology company working on medicines for RAS-addicted cancers, which are cancers driven by RAS gene changes. Its conference schedule puts management before healthcare-focused investors, giving them a chance to hear directly about the company's work.
Analyst inference
What to watch
- The Guggenheim fireside chat is scheduled for November 10 at 8:30 a.m. ET, and the Jefferies chat in London is set for November 16 at 5:30 a.m. ET. Confirmed
- Listen for whether management gives new details on its RAS(ON) inhibitor portfolio, which means drugs designed to target the active, cancer-driving state of RAS, or repeats earlier public information. Proposed
- Watch whether executives describe spending plans or cash needs tied to developing and selling its medicines, since those comments could affect how investors judge the company's finances. Analyst inference